ClinicalTrials.Veeva

Menu

Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

M

MemScreen

Status

Unknown

Conditions

Alzheimer Disease
Cognitive Impairment

Treatments

Diagnostic Test: MemScreen

Study type

Observational

Funder types

Industry

Identifiers

NCT03811184
2018-A02672-53

Details and patient eligibility

About

The clinical evaluation of a patient with a cognitive complaint requires neuropsychological tests, evaluating the integrity of memory and other cognitive functions.

The initial evaluation is made most often by a doctor (general practitioner). In case of need for further examination, a neuropsychological report is made in consultation memory by a neuropsychologist, with further cognitive tests.

The Cognitive Neurology Center at Lariboisière Hospital - Fernand Widal has developed a tool on a digital tablet or smartphone to evaluate cognitive functions: MemScreen.

The purpose of this study is to validate this new neuropsychological test on tablet compared to the neuropsychological reference tests.

Full description

Characteristics of MemScreen :

  • Smartphone / tablet application developed by the Cognitive Neurology Center at Lariboisière - Fernand Widal Hospital to explore a patient with a cognitive disorder.
  • The application is a self-test by the patient under the supervision of a doctor.
  • The doctor has an account to be able to pass the test to patients.
  • The tablet test is anonymous without the possibility to identify the patient.

Enrollment

400 estimated patients

Sex

All

Ages

40+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Major patients followed in memory clinic.
  • Performing a neuropsychological assessment less than 6 months old.
  • No visual or motor deficiency impeding the use of a digital tablet.

Exclusion criteria

  • None.

Trial design

400 participants in 1 patient group

MemScreen
Description:
Each participants will undergo MemScreen : a screening tool on smartphone for detecting mild cognitive impairment.
Treatment:
Diagnostic Test: MemScreen

Trial contacts and locations

1

Loading...

Central trial contact

Julien Dumurgier, MD; Claire Paquet, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems